296 related articles for article (PubMed ID: 15078706)
1. Predicting outcome and directing therapy for papillary thyroid carcinoma.
Kim S; Wei JP; Braveman JM; Brams DM
Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
[TBL] [Abstract][Full Text] [Related]
2. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
Cross S; Wei JP; Kim S; Brams DM
J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
[TBL] [Abstract][Full Text] [Related]
3. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
Haigh PI; Urbach DR; Rotstein LE
Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
[TBL] [Abstract][Full Text] [Related]
4. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
[TBL] [Abstract][Full Text] [Related]
5. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
6. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
7. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
8. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
Haigh PI; Urbach DR; Rotstein LE
Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
[TBL] [Abstract][Full Text] [Related]
9. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
13. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
15. Management of papillary microcarcinoma of the thyroid gland.
Orsenigo E; Beretta E; Fiacco E; Scaltrini F; Veronesi P; Invernizzi L; Gini P; Fiorina P; Di Carlo V
Eur J Surg Oncol; 2004 Dec; 30(10):1104-6. PubMed ID: 15522558
[TBL] [Abstract][Full Text] [Related]
16. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
17. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
19. Predictors of thyroid tumor aggressiveness.
Clark OH
West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
[TBL] [Abstract][Full Text] [Related]
20. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
